WellPoint & Alavert
This article was originally published in The Tan Sheet
Executive Summary
WellPoint Health Networks this month will mail three $10-off coupons for Wyeth's orally disintegrating loratadine to 438,000 members who received a prescription for a second-generation antihistamine within the past six months. Program marks WellPoint's first broad-scale couponing effort, although firm notes it has "dabbled" with coupons for OTC H2 antagonists in the past. WellPoint, which petitioned FDA to switch second-generation antihistamines OTC, says it approached Schering, Wyeth, McNeil about a cooperative marketing program for OTC loratadine and will split the couponing campaign's costs with Wyeth. In approving Alavert Dec. 23, FDA directed Wyeth to submit introductory promotional materials (1"The Tan Sheet" Dec. 23, 2002, p. 5). FDA says it also asked Schering to submit promotional materials for OTC Claritin; however, the request was made more informally and was not stated in the approval letters...
You may also be interested in...
Alavert promotions
Wyeth Consumer Healthcare is partnering with Aetna to provide Alavert coupons, information on OTC loratadine to roughly 475,000 of Aetna's commercial members who have received an Rx for any non-sedating antihistamine in the past year, healthcare provider announces Feb. 5. Mailings are slated to begin in February and end in early April, firm says. Wyeth also has engaged in an Alavert marketing program with WellPoint (1"The Tan Sheet" Jan. 6, 2003, In Brief)...
Wyeth Alavert Approval Sparks Loratadine Price Wars, Fight For OTC Share
Wyeth Consumer Healthcare is staking a claim to the OTC loratadine market with Alavert pricing of 56¢ to $1 per orally disintegrating tablet and high-value coupons
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.